Search - tctmd.com

Displaying 41 - 60 of 150

Sort: Relevancy | Date

TCT 354: The clinical impact of Dual Antiplatelet Therapy score combined with P2Y12 reactivity unit on East Asian patients who received drug eluting stent implantation; PTRG-DES Consortium

Presentation TCT 2023

TCT 354: The clinical impact of Dual Antiplatelet Therapy score combined with P2Y12 reactivity unit on East Asian patients who received drug eluting stent implantation; PTRG-DES Consortium

Presenter: Seong Huan Choi

October 25, 2023

TCT 37: The association of CHADS-P2A2RC risk score with clinical outcomes in patients taking P2Y12 inhibitor monotherapy after 3 months of dual antiplatelet therapy following percutaneous coronary intervention

Presentation TCT 2023

TCT 37: The association of CHADS-P2A2RC risk score with clinical outcomes in patients taking P2Y12 inhibitor monotherapy after 3 months of dual antiplatelet therapy following percutaneous coronary intervention

Presenter: Ji-Yeon Kim

October 25, 2023

TCT 30: Predicting Individual Treatment Effects to Determine Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation

Presentation TCT 2023

TCT 30: Predicting Individual Treatment Effects to Determine Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation

Presenter: Byeong-Keuk Kim

October 25, 2023

Long Term Maintenance Antiplatelet Therapy After PCI

Presentation TCT 2023

Long Term Maintenance Antiplatelet Therapy After PCI

Presenter: Hyo-Soo Kim

October 24, 2023

Dual Antiplatelet Therapy After PCI: Considerations for Duration and Choice Of Drug(s)

Presentation TCT 2023

Dual Antiplatelet Therapy After PCI: Considerations for Duration and Choice Of Drug(s)

Presenter: Jacqueline Tamis-Holland

October 24, 2023

De-Escalation of Antithrombotic Therapy: Why, in Whom, and How?

Presentation TCT 2023

De-Escalation of Antithrombotic Therapy: Why, in Whom, and How?

Presenter: Sripal Bangalore

October 24, 2023

Antiplatelet Agents for Patients Undergoing PCI: Options and Pharmacologic Considerations

Presentation TCT 2023

Antiplatelet Agents for Patients Undergoing PCI: Options and Pharmacologic Considerations

Presenter: Harold Dauerman

October 24, 2023

Standardizing the Language Around DAPT Post PCI: A Report From ARC With a Case Example

Presentation TCT 2023

Standardizing the Language Around DAPT Post PCI: A Report From ARC With a Case Example

Presenter: Dominick Angiolillo

October 24, 2023

Rosuvastatin, Atorvastatin: Similar Efficacy in LODESTAR, Some Differing Signals

News Daily News

Rosuvastatin, Atorvastatin: Similar Efficacy in LODESTAR, Some Differing Signals

Yael L. Maxwell

October 19, 2023

Surgeons Support Proposed Changes to Left Main CAD Guidelines

News Conference News EACTS 2023

Surgeons Support Proposed Changes to Left Main CAD Guidelines

Michael O'Riordan

October 13, 2023

Semaglutide Works Across LVEF Range: STEP-HFpEF Analysis

News Conference News HFSA 2023

Semaglutide Works Across LVEF Range: STEP-HFpEF Analysis

October 11, 2023

Positive Phase III Results Bring Excitement for Novel PET Imaging Tracer

News Daily News

Positive Phase III Results Bring Excitement for Novel PET Imaging Tracer

October 10, 2023

Clopidogrel Bests Aspirin Monotherapy After PCI Across Risk Strata

News Daily News

Clopidogrel Bests Aspirin Monotherapy After PCI Across Risk Strata

Yael L. Maxwell

October 09, 2023

Similar Outcomes With Enteric-Coated and Uncoated Aspirin: ADAPTABLE

News Daily News

Similar Outcomes With Enteric-Coated and Uncoated Aspirin: ADAPTABLE

October 06, 2023

October 2023 News Roundup

News Opinion CV Team Dispatch

October 2023 News Roundup

October 01, 2023

PET-Guided Strategy Lowers Risk, Boosts Outcomes in Stable CAD: CENTURY

News Daily News

PET-Guided Strategy Lowers Risk, Boosts Outcomes in Stable CAD: CENTURY

Michael O'Riordan

September 29, 2023

Angiogram-Derived Functional Tests Pre-TAVI: Simpler, Yes, but Warranted?

News Daily News

Angiogram-Derived Functional Tests Pre-TAVI: Simpler, Yes, but Warranted?

Michael O'Riordan

September 21, 2023

Aggressive Lipid-Lowering Very Unlikely to Hurt the Brain: AHA

News Daily News

Aggressive Lipid-Lowering Very Unlikely to Hurt the Brain: AHA

September 19, 2023

High-risk Plaques in Nonculprit Lesions Tied to Worse Post-MI Outcomes

News Daily News

High-risk Plaques in Nonculprit Lesions Tied to Worse Post-MI Outcomes

September 18, 2023

Evinacumab Helps Severe Hypercholesterolemia Patients Reach LDL Targets

News Daily News

Evinacumab Helps Severe Hypercholesterolemia Patients Reach LDL Targets

Michael O'Riordan

September 14, 2023

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.